微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00853 微创医疗

劳动节休市 04-30 16:08:13

8.710

-0.090

-1.02%

最高8.900	最低8.650	成交量765.82万
今开8.800	昨收8.800	日振幅2.84%
总市值166.97亿	流通市值166.97亿	总股本19.17亿
成交额6,689万	换手率0.40%	流通股本19.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":8.71,"timestamp":1777536493003,"preClose":8.8,"halted":0,"volume":7658163,"delay":0,"changeRate":-0.01022727272727271,"floatShares":1917000000,"shares":1917000000,"eps":0.11905246831377587,"marketStatus":"劳动节休市","change":-0.09,"latestTime":"04-30 16:08:13","open":8.8,"high":8.9,"low":8.65,"amount":66888774,"amplitude":0.028409,"askPrice":8.71,"askSize":26400,"bidPrice":8.7,"bidSize":4900,"shortable":3,"etf":0,"ttmEps":1.5431856992902915,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777858200000},"marketStatusCode":7,"adr":0,"listingDate":1285257600000,"exchange":"SEHK","adjPreClose":8.8,"openAndCloseTimeList":[[1777512600000,1777521600000],[1777525200000,1777536000000]],"volumeRatio":0.7116951174123534,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853","defaultTab":"news","newsList":[{"id":"1179411433","title":"微创医疗2025年营收逾11亿美元 多业务板块加速增长并实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1179411433","media":"公告速递","labels":["dataReport","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179411433?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:56","pubTimestamp":1777539372,"startTime":"0","endTime":"0","summary":"根据微创医疗年度报告，2025年公司收入达1,105,381千美元，较上一年度的1,031,063千美元增长7.2%，毛利由574,092千美元增至634,584千美元，同比增长10.5%。年内利润为38,427千美元，上一年度则为亏损268,459千美元；归属于本公司股东的利润由上一年度亏损214,043千美元转为48,519千美元，同比上升122.7%，标志着经营业绩成功扭亏为盈。资产结构方面，截至2025年12月31日，集团总资产为3,696,675千美元，流动资产与非流动资产分别为1,633,533千美元及2,063,142千美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微创医疗2025年营收逾11亿美元 多业务板块加速增长并实现扭亏为盈","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631592298","title":"微创医疗(00853)：心脉医疗科技第一季度股东应占净利润1.55亿元 同比增加19.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631592298","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631592298?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:40","pubTimestamp":1777459211,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布上海微创心脉医疗科技(集团)股份有限公司2026年第一季度业绩，该公司取得收入人民币3.7亿元(单位下同)，同比增加11.45%;归属于心脉医疗科技股权持有人的净利润1.55亿元，同比增加19.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436364.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00853","688016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146905906","title":"微创医疗2026年第一财季营收3.70亿元，经调整净利润1.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146905906","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146905906?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:31","pubTimestamp":1777458683,"startTime":"0","endTime":"0","summary":"本季度信息\n根据公告披露，微创医疗持股40.32%的上海微创心脉医疗科技（集团）股份有限公司（以下简称“心脉医疗科技”）于2026年第一财季实现营收3.70亿元，同比增长11.45%；经调整净利润1.55亿元，同比增长19.44%。公告显示，这部分业绩在微创医疗的财务报表中得到并表处理。\n业务分项\n本期财报仅披露了心脉医疗科技的营收及利润数据，公告未进一步细分业务板块具体经营表现。\n","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631589535","title":"微创医疗遭小摩减持约142.79万股 每股作价9.2016港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631589535","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631589535?lang=zh_cn&edition=full","pubTime":"2026-04-29 08:06","pubTimestamp":1777421160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新数据显示，4月22日，小摩减持微创医疗（00853）142.7872万股，每股作价9.2016港元，总金额约为1313.87万港元。减持后最新持股数目约为1.91亿股，最新持股比例为9.98%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-29/doc-inhwckrh8022337.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["JPO","LU2746668461.USD","00853","IE00B3S45H60.SGD","LU0211328371.USD","JPMO","LU0106831901.USD","LU1894683264.USD","LU0323591593.USD","LU1366192091.USD","LU1162221912.USD","LU0048584097.USD","LU0149725797.USD","LU1548497426.USD","BK4581","LU0211326839.USD","EWH","LU1988902786.USD","LU2462157665.USD","LU1670628061.USD","IE00BHPRN162.USD","LU2417539215.USD","LU0345770993.USD","LU2456880835.USD","BK1100","LU1496350171.SGD","LU2237443978.SGD","LU0882574139.USD","LU1551013425.SGD","LU2430703095.HKD","LU1917777945.USD","LU1267930490.SGD","LU0256863902.USD","BK1589","LU0345770308.USD","LU2023250330.USD","LU2237443895.HKD","LU1244550494.USD","LU2746668974.SGD","BK4207","LU0859254822.USD","IE00BJTD4N35.SGD","IE00BDRTCR15.USD","LU2552382132.HKD","IE00B1BXHZ80.USD","IE00BLSP4452.SGD","LU1720051108.HKD","LU2430703178.SGD","LU2237443622.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629849685","title":"摩根大通增持微创医疗(00853)约130.82万股 每股作价约9.47港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629849685","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629849685?lang=zh_cn&edition=full","pubTime":"2026-04-24 19:38","pubTimestamp":1777030711,"startTime":"0","endTime":"0","summary":"4月21日，摩根大通增持微创医疗(00853)130.8236万股，每股作价9.4702港元，总金额约为1238.93万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260424/20260424193920_56344.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260424/20260424193920_56344.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0868494708.USD","IE0034235188.USD","LU0689472784.USD","BK4534","LU1116320737.USD","LU1974910355.USD","LU2237443382.USD","IE00B1BXHZ80.USD","LU0106831901.USD","LU1894683348.USD","LU1366192091.USD","LU2264538146.SGD","LU0345770308.USD","LU2023250504.SGD","LU2552382058.USD","IE00BHPRN162.USD","EWH","LU1119994496.HKD","LU0256863811.USD","LU2357305700.SGD","LU2746668461.USD","LU1145028129.USD","LU2456880835.USD","JPO","LU0320765646.SGD","LU2505996509.AUD","LU1551013425.SGD","IE0034235303.USD","BK1583","LU0070302665.USD","LU1280957306.USD","LU0203347892.USD","JPMO","IE00BJTD4N35.SGD","BK4566","LU0149725797.USD","LU0170899867.USD","LU0265550359.USD","LU2237443978.SGD","IE00BJTD4V19.USD","LU0267386448.USD","IE00BLSP4239.USD","LU0345769631.USD","BK4504","LU1914381329.SGD","LU0971096721.USD","LU0006306889.USD","00853","LU2237443895.HKD","LU0942090050.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629087757","title":"【券商聚焦】中信建投：医疗器械板块拐点来临 26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629087757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629087757?lang=zh_cn&edition=full","pubTime":"2026-04-21 09:19","pubTimestamp":1776734371,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投研究认为，医疗器械板块拐点已经来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/N2I4ZDVmMTM1NjM3MTU3MjA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979495","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","01066","BK1584","02252","BK1222","BK1615","BK1591","LU0173614495.USD","BK1610","LU0287142896.SGD","02235","159883","BK1587","BK1247","BK0276","00241","BK1100","BK1593","02190","BK1600","BK1515","BK1585","BK1571","09996","BK1574","BK1502","BK1142","BK1589","BK1189","BK1583","BK1161","09997","01302","601066","00853","BK1501","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165954408","title":"异动解读 | 微创医疗盘中大跌5.11%，主要股东大举减持引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1165954408","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165954408?lang=zh_cn&edition=full","pubTime":"2026-04-17 10:55","pubTimestamp":1776394542,"startTime":"0","endTime":"0","summary":"微创医疗今日盘中股价大幅下跌5.11%，引起了投资者的广泛关注。消息面上，持股约8%的主要股东资本集团近期大举减持微创医疗，引发市场对公司基本面的担忧。作为长线资管巨头，资本集团此番近乎清仓式离场被市场解读为对公司持续亏损的“烧钱模式”失去耐心。财报显示，公司长期处于“增收不增利”的困境，连续多年录得巨额亏损。此外，市场对其依赖分拆子公司上市的资本运作模式存在质疑，港股投资者对平台型公司估值偏谨慎，公司仍需证明核心业务盈利能力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178920041","title":"微创医疗3月股份变动月报表：股本小幅增加115,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1178920041","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178920041?lang=zh_cn&edition=full","pubTime":"2026-04-09 16:43","pubTimestamp":1775724192,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司于2026年4月9日披露3月股份变动月报表，报告期截至2026年3月31日。报告显示，公司法定注册股本维持在5,000,000,000股，面值为每股USD 0.00001，总额USD 50,000，未发生变动。截至本报告期末，公司已发行股份由上月的1,917,257,655股增加至1,917,372,655股，增幅为115,000股。本次变动主要来自根据公司购股权计划行使期权所产生的新股发行，涉及资金总额HKD 400,430。公司无库藏股，各类股份在报告期内未发生回购和注销行为。公司表示将按照上市规则持续履行信息披露义务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625940173","title":"微创医疗(00853.HK)获摩根大通增持385.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625940173","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625940173?lang=zh_cn&edition=full","pubTime":"2026-04-08 22:47","pubTimestamp":1775659623,"startTime":"0","endTime":"0","summary":"格隆汇10月4日丨根据联交所最新权益披露资料显示，2024年9月27日，微创医疗(00853.HK)获JPMorgan Chase & Co.以每股均价6.1672港元增持好仓385.44万股，涉资约2377.1万港元。\r\n\r\n　　增持后，JPMorgan Chase & Co.最新持好仓数目为186,052,872股，持好仓比例由9.92%上升至10.13%。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/08/20260408983233.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/08/20260408983233.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260408/32132142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0211331839.USD","JPO","LU0683600562.USD","LU1116320737.USD","LU1551013425.SGD","LU0256863811.USD","BK4207","BK4534","IE00B1BXHZ80.USD","LU1366192091.USD","LU0070302665.USD","IE00BZ1G4Q59.USD","LU2023250330.USD","00853","LU2430703251.USD","IE00BBT3K403.USD","LU2430703178.SGD","LU2756315664.SGD","LU1551013342.USD","LU1974910355.USD","LU2023250504.SGD","LU0943347566.SGD","LU1496350171.SGD","LU1988902786.USD","IE00BHPRN162.USD","LU1145028129.USD","IE0034235188.USD","LU0787776722.HKD","BK4516","LU0203345920.USD","LU0320765489.SGD","LU1244550577.SGD","LU1894683348.USD","SG9999002224.SGD","LU0320765646.SGD","LU0882574139.USD","LU0267386448.USD","LU0006306889.USD","LU2242649171.HKD","IE000M9KFDE8.USD","LU0345770993.USD","IE00BWXC8680.SGD","LU2746668461.USD","LU1084165304.USD","BK4533","LU2357305700.SGD","LU2237443978.SGD","IE00BDRTCR15.USD","LU0211326755.USD","JPMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625865339","title":"中金：维持微创医疗(00853)跑赢行业评级 下调目标价至14.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2625865339","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625865339?lang=zh_cn&edition=full","pubTime":"2026-04-07 10:19","pubTimestamp":1775528394,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持微创医疗2026年归母净利润预测0.74亿美元不变，首次引入2027年归母净利润预测0.24亿美元。该行维持跑赢行业评级不变，基于DCF下调目标价15%至14.5港元，有58%上行空间。3)CRM业务收入2.30亿美元，整体持平，和微创心通整合后有望带来协同。降本增效和资产重组持续进行2025年毛利率提升1.7ppt至57.4%，运营费用率下降10.3ppt至57.4%。微创心通和CRM在25年12月完成整合，消除2.7亿美元回购义务，并有望实现协同降本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425360.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182994739","title":"异动解读 | 微创医疗盘中大跌5.27%，管理层变动引发市场担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1182994739","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182994739?lang=zh_cn&edition=full","pubTime":"2026-04-01 09:48","pubTimestamp":1775008115,"startTime":"0","endTime":"0","summary":"微创医疗(00853)今日盘中股价大幅下跌5.27%，引起了投资者的广泛关注。消息面上，公司于近期宣布成立全球执行委员会，并同步进行管理层调整。根据公告，自2026年4月1日起，公司董事会主席兼执行董事常兆华博士不再兼任公司首席执行官职务，但仍将担任全球运营指导委员会主席和首席科学官。公司轮值首席执行官Jonathan W Chen先生自同日起生效。董事会认为，成立全球执行委员会将有助于提升集团全球业务协同效率与管理效能。然而，市场可能将此次高层管理职务的调整，特别是首席执行官职务的变更，解读为公司战略执行或管理层稳定性存在不确定性，从而引发了抛售压力，导致股价在盘中出现显著下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624536648","title":"微创医疗(00853)成立全球执行委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=2624536648","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624536648?lang=zh_cn&edition=full","pubTime":"2026-04-01 00:11","pubTimestamp":1774973488,"startTime":"0","endTime":"0","summary":"董事会认为，成立全球执行委员会将有助于进一步提升集团全球业务协同效率与管理效能，强化集团战略执行能力，符合公司及全体股东的整体利益。自2026年4月1日起，公司董事会主席兼执行董事常兆华博士不再兼任公司首席执行官职务，但仍以全球运营指导委员会主席 和首席科学官身份继续专注于为集团制定总体发展战略规划、打造一体化产业生态及促进前沿科技创新等相关工作，从而保障集团的可持续性发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423566.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1100","00853","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127790126","title":"微创医疗公布财年净利润4850万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1127790126","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127790126?lang=zh_cn&edition=full","pubTime":"2026-03-31 23:38","pubTimestamp":1774971526,"startTime":"0","endTime":"0","summary":"微创医疗科学公司（0853.HK）公布截至3月31日的财年业绩报告。财年归属于公司股东的净利润达到4850万美元，全年总营收为11.1亿美元。\n业绩数据显示，公司在过去一年中保持了稳健的财务表现。营收规模突破十亿美元大关，盈利能力持续改善。此次公布的财报数据将为投资者评估公司经营状况提供重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1583","BK1100","BK1589","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623381255","title":"微创医疗(00853)公布2025年业绩 权益股东应占溢利4851.9万美元 同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2623381255","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623381255?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:48","pubTimestamp":1774968534,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗 公布2025年业绩，收入约11.05亿美元，同比增长6%;公司权益股东应占溢利4851.9万美元，同比扭亏为盈;基本每股溢利2.59美分。经营性现金流同步转正，取得6910万美元。报告期内，该集团“全球通”商业化平台取得积极进展，推动相关业务收入同比增长78.8%至1.639亿美元，并于报告期内实现盈亏平衡。报告期内，集团完成结构性心脏病业务与心律管理业务的战略整合.此次整合不仅优化了运营效率，亦使集团报表健康度明显提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"微创医疗(00853)公布2025年业绩 权益股东应占溢利4851.9万美元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1589","BK1583","00853","BK1585","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623912538","title":"微创医疗(00853)：杨兆琳获委任为公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2623912538","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623912538?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:46","pubTimestamp":1774968404,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗(00853)发布公告，袁颕欣女士已辞任公司公司秘书，及不再担任根据香港联合交易所有限公司证券上市规则第3.05条所规定的本公司授权代表，均自2026年3月31日起生效。杨兆琳女士已获委任接替袁女士为公司秘书及授权代表，均自2026年3月31日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423445.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1585","BK1589","BK1583","00853","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145714960","title":"微创医疗2025年营收13.51亿元，经调整净利润5.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145714960","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145714960?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:52","pubTimestamp":1774882379,"startTime":"0","endTime":"0","summary":"本季度信息\n根据公告，截至2025年12月31日止12个月，微创医疗持股40.32%的子公司心脉医疗科技实现营收13.51亿元，同比增长11.96%。经调整净利润5.63亿元，同比增长12.19%。财务数据依据中国会计准则编制，并已纳入微创医疗的合并报表。\n此外，心脉医疗科技总资产达46.41亿元，同比增长8.15%；归属于心脉医疗科技股权持有人的总权益为40.75亿元，同比增长7.48%。\n业务分项\n公告未提及具体业务分项与对应表现。\n高管解读\n公告未披露相关高管发言。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622818008","title":"【券商聚焦】中信建投：医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2622818008","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622818008?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:18","pubTimestamp":1774487918,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投表示，医疗器械板块拐点来临，26年业绩改善个股存在业绩估值修复机会。建议持续关注市场空间大、国产化率低的创新器械赛道，以及并购重组、脑机接口、AI医疗、手术机器人、外骨骼机器人等主题方向的投资机会。潜在催化较多的方向有望出现涨幅数倍的个股，未来AI医疗、脑机接口等也有望成为投资人重点关注的新科技方向。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977292","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1247","BK1615","BK1617","BK1583","BK1591","01066","LU0173614495.USD","09996","BK1610","BK1571","01302","BK1100","BK0276","601066","LU0287142896.SGD","09997","159883","BK1142","BK1589","BK1593","BK1501","00241","02235","02252","BK1161","BK1222","BK1587","BK1584","06826","BK1189","BK1574","BK1502","BK1515","02190","BK1585","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620245677","title":"微创医疗(00853.HK)拟3月31日举行董事会会议审批年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2620245677","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620245677?lang=zh_cn&edition=full","pubTime":"2026-03-19 17:27","pubTimestamp":1773912425,"startTime":"0","endTime":"0","summary":"格隆汇3月19日丨微创医疗(00853.HK)发布公告，谨定于2026年3月31日(星期二)举行董事会会议，藉以(其中包括)考虑及通过集团截至2025年12月31日止年度的全年业绩，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260319/32081828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1589","BK1100","00853","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619196305","title":"微创医疗03月13日遭主力抛售1446.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196305","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619196305?lang=zh_cn&edition=full","pubTime":"2026-03-13 16:16","pubTimestamp":1773389768,"startTime":"0","endTime":"0","summary":"03月13日, 微创医疗股价跌0.10%，报收10.14元，成交金额1.1亿元，换手率0.57%，振幅3.15%，量比0.92。微创医疗今日主力资金净流出1446.4万元，连续3日净流出，上一交易日主力净流出806.4万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为70.59%，平均跌幅为2.29%。该股近5个交易日下跌2.79%，主力资金累计净流出3187.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5310.9万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313162241a46634c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260313162241a46634c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1583","BK1100","BK1589","00853"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2618366069","title":"微创医疗03月10日主力净流入265.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2618366069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618366069?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:15","pubTimestamp":1773130547,"startTime":"0","endTime":"0","summary":"03月10日, 微创医疗股价涨2.19%，报收10.28元，成交金额1.0亿元，换手率0.52%，振幅2.68%，量比0.74。微创医疗今日主力资金净流入265.3万元，上一交易日主力净流出439.2万元。该股近5个交易日上涨1.28%，主力资金累计净流出2093.0万元；近20日主力资金累计净流出3424.8万元，其中净流出天数为12日。该股主力净额占比0.01%，港股市场排名313/2721。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161910a45dea1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310161910a45dea1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","00853","BK1100","BK1589","BK1585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":-0.0407},{"period":"1month","weight":-0.0812},{"period":"3month","weight":-0.26},{"period":"6month","weight":-0.2808},{"period":"1year","weight":0.2372},{"period":"ytd","weight":-0.195}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0399},{"period":"3month","weight":-0.0588},{"period":"6month","weight":-0.005},{"period":"1year","weight":0.1653},{"period":"ytd","weight":0.0057}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括“L-REBOA”主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009025},{"month":2,"riseRate":0.4375,"avgChangeRate":0.009312},{"month":3,"riseRate":0.5,"avgChangeRate":0.015172},{"month":4,"riseRate":0.375,"avgChangeRate":0.012111},{"month":5,"riseRate":0.6,"avgChangeRate":0.031457},{"month":6,"riseRate":0.466667,"avgChangeRate":0.048202},{"month":7,"riseRate":0.533333,"avgChangeRate":0.029792},{"month":8,"riseRate":0.266667,"avgChangeRate":-0.055578},{"month":9,"riseRate":0.6,"avgChangeRate":0.032463},{"month":10,"riseRate":0.625,"avgChangeRate":0.009684},{"month":11,"riseRate":0.4375,"avgChangeRate":0.005167},{"month":12,"riseRate":0.375,"avgChangeRate":-0.015138}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}